Focus: European governments scramble to interpret Trump's new drug pricing order

Contributing sentiments towards policy:

53% : " The country of six million has benefited from the expansion of Novo Nordisk (NOVOb.CO), opens new tab and the outsize demand for its diabetes drug Ozempic and for Wegovy, one of the powerful new weight-loss drugs singled out by Trump in his push to lower prices.
46% : "We know the pharmaceutical industry faces challenges both in the U.S. and the EU," the spokesperson said, noting Commission President Ursula von der Leyen had met with executives last month to address concerns about the threat of U.S. tariffs on medicines.
45% : On Monday, Trump took aim at governments paying a fraction of what Americans have to shell out for their medicines, and directed the use of trade policy to force other nations to pay more for prescription drugs.
39% : Trump said if drugmakers do not cut prices they could be hit with tariffs.
37% : "The United States will no longer subsidize the healthcare of foreign countries, which is what we were doing," Trump said on Monday.
34% : The message from Trump does not change that.

*Our bias meter rating uses data science including sentiment analysis, machine learning and our proprietary algorithm for determining biases in news articles. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral. The rating is an independent analysis and is not affiliated nor sponsored by the news source or any other organization.